Meeting Information

https://hl7-org.zoom.us/j/91297869819?pwd=cm81Yk1CQW9uUkQ1Y2FucEI2RU01UT09

Meeting ID: 912 9786 9819

Passcode: 594748

Chair:  Jess

Scribe: Jess

Antitrust Statement:

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM)

Attendees

Attendee type:

T - TSMG Member

O - observer

L - liaison

Present

P - present

A - Apologies

X- Proxy

Name

Affiliation

TP

Roel Barelds

Precipius b.v.

T
Sylvia ThunHL7 Germany
TACarol MacumberClinical Architecture
TAReuben DanielsSaludax
TADavera GabrielJohns Hopkins University BIDS
L
Suzy RoySNOMED International
O
Andrea MacLeanCanada Health Infoway
TPJessica BotaUTG/Apelon
O
Ted KleinKlein Consulting / HL7 UTG / Vocabulary WG CoChair
L
Rob HausamVocabulary WG CoChair
O
Mareike PrzysuchaHL7 Germany
TPRob McClureUS Realm Liaison
O
Rory DavidsonSNOMED International
O
Diana WrightLantana Consulting Group
O
Joel SchneiderNMDP/CIBMTR
O
Joanie HarperCanada Health Infoway
O
Carl LeitnerWorld Health Organization (WHO)
O
Chris MeloPhilips Health Care
O
Martha JonesICHOM
T
Michael FaughnNIST
O
Kris Gray
O
Hope GrayU of Alabama - Birmingham - HL7 Intern
T
Peter JordanHL7 New Zealand
O
Umanga De SilvaICHOM
O
Greg RobinsonICHOM
OPKevin PowerChildren's Mercy Hospital
OPScott CaseyChildren's Mercy Hospital
OPAndrea GaedigkChildren's Mercy Hospital

Minutes of previous teleconference (2022-10-13)

Agenda Topics


Agenda Outline

Agenda Item

StatusLead

Meeting Minutes from Discussion

Management

Quorum

TC Minutes Approval

Announcements

N/AReuben
  • Plan is to move call back an hour following DST
    • 8 AM ET
  • Will need to let TSMG know of time change
TopicPharmVarNewKevin Power
  • Reviewed PharmVar content via https://www.pharmvar.org/genes
  • General agreement that this is a code system where concepts are unique
  • Agreed to add more information to the code system metadata record page: Pharmacogene Variation (PharmVar)
    • The concept identifier is the PharmVar ID (these are unique)
    • Display name is in column 1 (Allele Name)
    • Remaining columns are properties (Legacy Label, Variants, etc.)
    • Code system is represented with is-a hierarchy
  • Likely no need for a convenience copy for implementers as they will likely only be interested in certain portions of PharmVar
  • Kevin and team will review HTA page once updated with this information
    • Page has been updated and Kevin has been tagged to review
Topic 211LANewRob M
  • Removed hanging backslash from uri
Topic

UTG/THO Update


ContinuousJess and Reuben

Topic

External SDO and Code System Issues

(review JIRA tickets https://jira.hl7.org/projects/HTA/summary) 

ContinuousCarol/ Reuben

DID NOT DISCUSS ON 11/10

JIRA Dashboard in progress https://jira.hl7.org/secure/Dashboard.jspa?selectPageId=13701

W3C DID

HTA-92 - Getting issue details... STATUS

ICD-11 MMS

HTA-117 - Getting issue details... STATUS

Medi-Span Electronic Drug File

HTA-116 - Getting issue details... STATUS

UDAP Capability Rest Security Service

HTA-93 - Getting issue details... STATUS

UICC TNM Staging

HTA-90 - Getting issue details... STATUS

  • Drafted page reviewed by requestor, ready to be approved by HTA
  • RM: Need clarification if those alternate oids are identifiers or version identifiers
    • Can move forward with current identifiers
    • Send note to Kai and Sylvia to show how we plan to represent UICC TNM and note that previous editions are not represented as alternate OIDs (last part of OID looks like it is being treated as version but confirmed it is not just for this code system so not a root we can tie to)
  • Will seek clarification prior to approving metadata for addition to THO

X12 Insurance Type

CDA-1513 - Getting issue details... STATUS

  • Pending review by someone who knows the X12 content to determine what is the definitive source
  • Asked Mary Kay to draft a page and HTA will review when ready

HGNC

  • Joel to propose updated text for what should be used for the code and HTA will review and update the resources as necessary

GL String Code

HTA-84 - Getting issue details... STATUS

  • Joel will follow up to make progress on this one

Reviewed the ticket and marked as In Progress pending additional information from implementers

Pharmacogenomic Star Alleles (PharmVar Pharmacogene Variation Consortium)

HTA-85 - Getting issue details... STATUS

  • Initial review complete. Invited submitter to an HTA call for further information.
  • Will attend 11/10 HTA call

PGKB-ClinAnnLevels

  • HTA-70 - Getting issue details... STATUS

2022-04-21:

    • RD to discuss with Carol about creation of a Confluence page.

ICPC, ICPC-DAN

Discussion:

ISO-21089



Topic

FHIR Tracker: OID specified on page for ICD-9CM is registered for ICD-9

Continued from previousReuben
  • The OID 2.16.840.1.113883.6.42 is stated in
  • The OID 2.16.840.1.113883.6.2 is stated in
    • THO/UTG's ICD-9-CM Code System Metadata Record as the OID for ICD-9-CM
    • the HL7 OID Registry as a retired OID for ICD-9CM with the following note: Note that this has been retired in favor of an explicit split between the diagnosis codes and the procedures codes as per the Vocabulary TC decision on Wednesday Q4, January 21, 2004.  Replaced by 2.16.840.1.113883.6.103 and 2.16.840.1.113883.6.104 as voted by committee.  -T. Klein
  • The OID 2.16.840.1.113883.6.103 is stated in
  • The OID 2.16.840.1.113883.6.104 is stated in
    • the HL7 OID Registry as the OID for ICD-9CM (procedure codes)
  • Requirement:
    • What are the correct OIDs for
      • ICD-9; and
      • ICD-9-CM 
  • Rob McClure to provide an update after checking in with the US Realm group.  No Update

2022-04-21:

  • RD to discuss with Rob McClure.
Topic

Any Other Business


ContinuousRD
AdjournmentMeeting adjournedN/ARD

Call adjourned at 10:00AM

  • No labels